Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Graft Central currently has 1 pending office action within the Chemistry & Materials technology area. This action is handled by 1 distinct examiner, BRAZIN, JACQUELINE, who is responsible for 1 pending office action. The assignment of the company's only active matter to 1 distinct examiner indicates a very narrow prosecution focus at this time.
The portfolio is situated within 1 distinct art unit, suggesting that the technical subject matter is confined to a specific chemical classification. Because BRAZIN, JACQUELINE manages the 1 pending action, her individual examination style will be the primary factor in the portfolio's progress. This concentration within 1 distinct art unit means that the company is not currently managing multiple technical standards across different fields.
With 1 pending office action and 1 distinct examiner, the prosecution path is direct. The fact that BRAZIN, JACQUELINE is the only examiner involved means that the company's success depends on resolving the specific issues raised in this 1 pending action. Practitioners should note that the lack of multiple pending matters or examiners simplifies the docket but increases the importance of this single interaction.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BRAZIN, JACQUELINE | 1 | 65.6% | +52.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18687840 | DEVICE AND METHOD FOR MONITORING A TRANSPLANT | BRAZIN, JACQUELINE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18687840 | DEVICE AND METHOD FOR MONITORING A TRANSPLANT | BRAZIN, JACQUELINE | — |
| Art Unit | Apps |
|---|---|
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18687840 | DEVICE AND METHOD FOR MONITORING A TRANSPLANT | BRAZIN, JACQUELINE | 1798 | §102§103 | Non-Final OA | — | Pending | Feb 29, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGraft Central has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jacqueline Brazin has the most, with 1 of Graft Central's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
